Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

262.03 5.90 −2.20%
Market cap
$40.5B
P/E
48.4×
Fwd P/E
34.7×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a

Illumina, Inc. (ILMN) Book value per share

Alert me on Book value per share

Illumina, Inc.'s book value per share at the end of fiscal 2025 was 17.6×, up 17.7% from 14.9× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 18.8×. Over the past ten years it has ranged from 12.7× (fiscal 2015) to 71.6× (fiscal 2021); the current reading is higher than 36% of that period. Illumina, Inc. ranks 14th of 52 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 17.6× 17.71%
FY2024 14.9× (58.95%)
FY2023 36.4× (13.49%)
FY2022 42.0× (41.30%)
FY2021 71.6× 124.23%
FY2020 31.9× 1.76%
FY2019 31.4× 19.97%
FY2018 26.2× 38.92%
FY2017 18.8× 21.93%
FY2016 15.4× 21.13%

Quarterly newest first

Period Book value per share Change
Jun 2026 18.8× 7.46%
Mar 2026 17.5× (0.44%)
Dec 2025 17.6× 12.89%
Sep 2025 15.6× 8.20%
42 more quarters

Against its own ten years

Low 12.7× High 71.6×
Ten-year median 26.2×
Current reading's percentile 36

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on ILMN